Home Healthcare Biotechnology Companion Diagnostics for Oncology Market

Companion Diagnostics for Oncology Market Size, Share & Trends Analysis Report By Products and Services (Assays, Kits, and Reagents, Software and Services), By Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS)), By Indication (Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Melanoma, Others), By End-User (Pharmaceutical and Biopharmaceutical Companies, Laboratories, Contract Research Organizations, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Companion Diagnostics for Oncology Market Size Analysis
    1. Introduction
    2. Companion Diagnostics for Oncology Market Market Size & Forecast By Products and Services 2022-2034 (USD MILLION/ Units)
      1. Assays, Kits, and Reagents
      2. Software and Services
    3. Companion Diagnostics for Oncology Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Polymerase Chain Reaction (PCR)
      2. Next-Generation Sequencing (NGS)
    4. Companion Diagnostics for Oncology Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Breast Cancer
      2. Lung Cancer
      3. Colorectal Cancer
      4. Gastric Cancer
      5. Melanoma
      6. Others
    5. Companion Diagnostics for Oncology Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical and Biopharmaceutical Companies
      2. Laboratories
      3. Contract Research Organizations
      4. Others
  7. North America Companion Diagnostics for Oncology Market Size Analysis
    1. Introduction
    2. Companion Diagnostics for Oncology Market Market Size & Forecast By Products and Services 2022-2034 (USD MILLION/ Units)
      1. Assays, Kits, and Reagents
      2. Software and Services
    3. Companion Diagnostics for Oncology Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Polymerase Chain Reaction (PCR)
      2. Next-Generation Sequencing (NGS)
    4. Companion Diagnostics for Oncology Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Breast Cancer
      2. Lung Cancer
      3. Colorectal Cancer
      4. Gastric Cancer
      5. Melanoma
      6. Others
    5. Companion Diagnostics for Oncology Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical and Biopharmaceutical Companies
      2. Laboratories
      3. Contract Research Organizations
      4. Others
    6. U.S.
      1. Introduction
      2. Market Size & Forecast By Products and Services 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Software and Services
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Next-Generation Sequencing (NGS)
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Gastric Cancer
        5. Melanoma
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Laboratories
        3. Contract Research Organizations
        4. Others
    7. Canada
      1. Introduction
      2. Market Size & Forecast By Products and Services 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Software and Services
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Next-Generation Sequencing (NGS)
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Gastric Cancer
        5. Melanoma
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Laboratories
        3. Contract Research Organizations
        4. Others
  8. Europe Companion Diagnostics for Oncology Market Size Analysis
    1. Introduction
    2. Companion Diagnostics for Oncology Market Market Size & Forecast By Products and Services 2022-2034 (USD MILLION/ Units)
      1. Assays, Kits, and Reagents
      2. Software and Services
    3. Companion Diagnostics for Oncology Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Polymerase Chain Reaction (PCR)
      2. Next-Generation Sequencing (NGS)
    4. Companion Diagnostics for Oncology Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Breast Cancer
      2. Lung Cancer
      3. Colorectal Cancer
      4. Gastric Cancer
      5. Melanoma
      6. Others
    5. Companion Diagnostics for Oncology Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical and Biopharmaceutical Companies
      2. Laboratories
      3. Contract Research Organizations
      4. Others
    6. U.K.
      1. Introduction
      2. Market Size & Forecast By Products and Services 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Software and Services
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Next-Generation Sequencing (NGS)
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Gastric Cancer
        5. Melanoma
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Laboratories
        3. Contract Research Organizations
        4. Others
    7. Germany
      1. Introduction
      2. Market Size & Forecast By Products and Services 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Software and Services
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Next-Generation Sequencing (NGS)
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Gastric Cancer
        5. Melanoma
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Laboratories
        3. Contract Research Organizations
        4. Others
    8. France
      1. Introduction
      2. Market Size & Forecast By Products and Services 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Software and Services
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Next-Generation Sequencing (NGS)
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Gastric Cancer
        5. Melanoma
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Laboratories
        3. Contract Research Organizations
        4. Others
    9. Spain
      1. Introduction
      2. Market Size & Forecast By Products and Services 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Software and Services
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Next-Generation Sequencing (NGS)
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Gastric Cancer
        5. Melanoma
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Laboratories
        3. Contract Research Organizations
        4. Others
    10. Italy
      1. Introduction
      2. Market Size & Forecast By Products and Services 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Software and Services
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Next-Generation Sequencing (NGS)
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Gastric Cancer
        5. Melanoma
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Laboratories
        3. Contract Research Organizations
        4. Others
    11. Russia
      1. Introduction
      2. Market Size & Forecast By Products and Services 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Software and Services
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Next-Generation Sequencing (NGS)
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Gastric Cancer
        5. Melanoma
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Laboratories
        3. Contract Research Organizations
        4. Others
    12. Nordic
      1. Introduction
      2. Market Size & Forecast By Products and Services 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Software and Services
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Next-Generation Sequencing (NGS)
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Gastric Cancer
        5. Melanoma
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Laboratories
        3. Contract Research Organizations
        4. Others
    13. Benelux
      1. Introduction
      2. Market Size & Forecast By Products and Services 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Software and Services
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Next-Generation Sequencing (NGS)
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Gastric Cancer
        5. Melanoma
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Laboratories
        3. Contract Research Organizations
        4. Others
    14. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Products and Services 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Software and Services
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Next-Generation Sequencing (NGS)
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Gastric Cancer
        5. Melanoma
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Laboratories
        3. Contract Research Organizations
        4. Others
  9. APAC Companion Diagnostics for Oncology Market Size Analysis
    1. Introduction
    2. Companion Diagnostics for Oncology Market Market Size & Forecast By Products and Services 2022-2034 (USD MILLION/ Units)
      1. Assays, Kits, and Reagents
      2. Software and Services
    3. Companion Diagnostics for Oncology Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Polymerase Chain Reaction (PCR)
      2. Next-Generation Sequencing (NGS)
    4. Companion Diagnostics for Oncology Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Breast Cancer
      2. Lung Cancer
      3. Colorectal Cancer
      4. Gastric Cancer
      5. Melanoma
      6. Others
    5. Companion Diagnostics for Oncology Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical and Biopharmaceutical Companies
      2. Laboratories
      3. Contract Research Organizations
      4. Others
    6. China
      1. Introduction
      2. Market Size & Forecast By Products and Services 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Software and Services
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Next-Generation Sequencing (NGS)
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Gastric Cancer
        5. Melanoma
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Laboratories
        3. Contract Research Organizations
        4. Others
    7. Korea
      1. Introduction
      2. Market Size & Forecast By Products and Services 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Software and Services
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Next-Generation Sequencing (NGS)
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Gastric Cancer
        5. Melanoma
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Laboratories
        3. Contract Research Organizations
        4. Others
    8. Japan
      1. Introduction
      2. Market Size & Forecast By Products and Services 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Software and Services
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Next-Generation Sequencing (NGS)
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Gastric Cancer
        5. Melanoma
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Laboratories
        3. Contract Research Organizations
        4. Others
    9. India
      1. Introduction
      2. Market Size & Forecast By Products and Services 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Software and Services
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Next-Generation Sequencing (NGS)
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Gastric Cancer
        5. Melanoma
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Laboratories
        3. Contract Research Organizations
        4. Others
    10. Australia
      1. Introduction
      2. Market Size & Forecast By Products and Services 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Software and Services
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Next-Generation Sequencing (NGS)
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Gastric Cancer
        5. Melanoma
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Laboratories
        3. Contract Research Organizations
        4. Others
    11. Taiwan
      1. Introduction
      2. Market Size & Forecast By Products and Services 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Software and Services
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Next-Generation Sequencing (NGS)
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Gastric Cancer
        5. Melanoma
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Laboratories
        3. Contract Research Organizations
        4. Others
    12. South East Asia
      1. Introduction
      2. Market Size & Forecast By Products and Services 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Software and Services
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Next-Generation Sequencing (NGS)
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Gastric Cancer
        5. Melanoma
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Laboratories
        3. Contract Research Organizations
        4. Others
    13. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Products and Services 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Software and Services
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Next-Generation Sequencing (NGS)
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Gastric Cancer
        5. Melanoma
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Laboratories
        3. Contract Research Organizations
        4. Others
  10. Middle East and Africa Companion Diagnostics for Oncology Market Size Analysis
    1. Introduction
    2. Companion Diagnostics for Oncology Market Market Size & Forecast By Products and Services 2022-2034 (USD MILLION/ Units)
      1. Assays, Kits, and Reagents
      2. Software and Services
    3. Companion Diagnostics for Oncology Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Polymerase Chain Reaction (PCR)
      2. Next-Generation Sequencing (NGS)
    4. Companion Diagnostics for Oncology Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Breast Cancer
      2. Lung Cancer
      3. Colorectal Cancer
      4. Gastric Cancer
      5. Melanoma
      6. Others
    5. Companion Diagnostics for Oncology Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical and Biopharmaceutical Companies
      2. Laboratories
      3. Contract Research Organizations
      4. Others
    6. UAE
      1. Introduction
      2. Market Size & Forecast By Products and Services 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Software and Services
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Next-Generation Sequencing (NGS)
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Gastric Cancer
        5. Melanoma
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Laboratories
        3. Contract Research Organizations
        4. Others
    7. Turkey
      1. Introduction
      2. Market Size & Forecast By Products and Services 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Software and Services
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Next-Generation Sequencing (NGS)
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Gastric Cancer
        5. Melanoma
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Laboratories
        3. Contract Research Organizations
        4. Others
    8. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Products and Services 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Software and Services
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Next-Generation Sequencing (NGS)
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Gastric Cancer
        5. Melanoma
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Laboratories
        3. Contract Research Organizations
        4. Others
    9. South Africa
      1. Introduction
      2. Market Size & Forecast By Products and Services 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Software and Services
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Next-Generation Sequencing (NGS)
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Gastric Cancer
        5. Melanoma
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Laboratories
        3. Contract Research Organizations
        4. Others
    10. Egypt
      1. Introduction
      2. Market Size & Forecast By Products and Services 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Software and Services
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Next-Generation Sequencing (NGS)
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Gastric Cancer
        5. Melanoma
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Laboratories
        3. Contract Research Organizations
        4. Others
    11. Nigeria
      1. Introduction
      2. Market Size & Forecast By Products and Services 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Software and Services
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Next-Generation Sequencing (NGS)
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Gastric Cancer
        5. Melanoma
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Laboratories
        3. Contract Research Organizations
        4. Others
    12. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Products and Services 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Software and Services
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Next-Generation Sequencing (NGS)
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Gastric Cancer
        5. Melanoma
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Laboratories
        3. Contract Research Organizations
        4. Others
  11. LATAM Companion Diagnostics for Oncology Market Size Analysis
    1. Introduction
    2. Companion Diagnostics for Oncology Market Market Size & Forecast By Products and Services 2022-2034 (USD MILLION/ Units)
      1. Assays, Kits, and Reagents
      2. Software and Services
    3. Companion Diagnostics for Oncology Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Polymerase Chain Reaction (PCR)
      2. Next-Generation Sequencing (NGS)
    4. Companion Diagnostics for Oncology Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Breast Cancer
      2. Lung Cancer
      3. Colorectal Cancer
      4. Gastric Cancer
      5. Melanoma
      6. Others
    5. Companion Diagnostics for Oncology Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical and Biopharmaceutical Companies
      2. Laboratories
      3. Contract Research Organizations
      4. Others
    6. Brazil
      1. Introduction
      2. Market Size & Forecast By Products and Services 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Software and Services
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Next-Generation Sequencing (NGS)
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Gastric Cancer
        5. Melanoma
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Laboratories
        3. Contract Research Organizations
        4. Others
    7. Mexico
      1. Introduction
      2. Market Size & Forecast By Products and Services 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Software and Services
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Next-Generation Sequencing (NGS)
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Gastric Cancer
        5. Melanoma
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Laboratories
        3. Contract Research Organizations
        4. Others
    8. Argentina
      1. Introduction
      2. Market Size & Forecast By Products and Services 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Software and Services
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Next-Generation Sequencing (NGS)
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Gastric Cancer
        5. Melanoma
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Laboratories
        3. Contract Research Organizations
        4. Others
    9. Chile
      1. Introduction
      2. Market Size & Forecast By Products and Services 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Software and Services
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Next-Generation Sequencing (NGS)
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Gastric Cancer
        5. Melanoma
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Laboratories
        3. Contract Research Organizations
        4. Others
    10. Colombia
      1. Introduction
      2. Market Size & Forecast By Products and Services 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Software and Services
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Next-Generation Sequencing (NGS)
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Gastric Cancer
        5. Melanoma
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Laboratories
        3. Contract Research Organizations
        4. Others
    11. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Products and Services 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Software and Services
      3. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Next-Generation Sequencing (NGS)
      4. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Gastric Cancer
        5. Melanoma
        6. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Laboratories
        3. Contract Research Organizations
        4. Others
  12. Competitive Landscape
    1. Companion Diagnostics for Oncology Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Qiagen N.V.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. F. Hoffmann La Roche Ltd
    3. Agilent Technologies
    4. Thermo Fisher Scientific
    5. Abbott
    6. Amoy diagnostics
    7. BioMérieux SA
    8. Archerdx
    9. Illumina, Inc.
    10. Foundation Medicine, Inc.
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.